DK3247711T3 - Hidtil ukendte salte og polymorfer af scy-078 - Google Patents

Hidtil ukendte salte og polymorfer af scy-078 Download PDF

Info

Publication number
DK3247711T3
DK3247711T3 DK16703009.7T DK16703009T DK3247711T3 DK 3247711 T3 DK3247711 T3 DK 3247711T3 DK 16703009 T DK16703009 T DK 16703009T DK 3247711 T3 DK3247711 T3 DK 3247711T3
Authority
DK
Denmark
Prior art keywords
polymorphes
scy
still unknown
salts
unknown salts
Prior art date
Application number
DK16703009.7T
Other languages
English (en)
Inventor
Yi Zhang
Original Assignee
Scynexis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55300785&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3247711(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scynexis Inc filed Critical Scynexis Inc
Application granted granted Critical
Publication of DK3247711T3 publication Critical patent/DK3247711T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265Citric acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
DK16703009.7T 2015-01-19 2016-01-14 Hidtil ukendte salte og polymorfer af scy-078 DK3247711T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNPCT/CN2015/070967 2015-01-19
PCT/US2016/013356 WO2016118396A1 (en) 2015-01-19 2016-01-14 Novel salts and polymorphs of scy-078

Publications (1)

Publication Number Publication Date
DK3247711T3 true DK3247711T3 (da) 2022-05-09

Family

ID=55300785

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16703009.7T DK3247711T3 (da) 2015-01-19 2016-01-14 Hidtil ukendte salte og polymorfer af scy-078

Country Status (14)

Country Link
US (4) US10174074B2 (da)
EP (2) EP4039684A1 (da)
DK (1) DK3247711T3 (da)
EA (1) EA036874B1 (da)
ES (1) ES2913111T3 (da)
HK (1) HK1247196A1 (da)
HR (1) HRP20220544T1 (da)
HU (1) HUE058721T2 (da)
LT (1) LT3247711T (da)
PL (1) PL3247711T3 (da)
PT (1) PT3247711T (da)
RS (1) RS63234B1 (da)
SI (1) SI3247711T1 (da)
WO (1) WO2016118396A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016118396A1 (en) 2015-01-19 2016-07-28 Scynexis, Inc. Novel salts and polymorphs of scy-078
MX2019012116A (es) 2017-04-10 2019-11-21 Scynexis Inc Agentes antifungicos utilizados en combinacion.
AU2018309718A1 (en) * 2017-08-04 2020-02-27 Scynexis, Inc. Antifungal agents with enhanced activity in acidic pH
CN115998684A (zh) * 2018-01-02 2023-04-25 西尼克斯公司 包覆于脂质体中的三萜类抗真菌剂的可注射组合物
WO2021092349A1 (en) 2019-11-08 2021-05-14 Scynexis, Inc. Lipid-based formulations of scy-078 salts

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ590914A (en) 2008-08-12 2011-11-25 Merck Sharp & Dohme Triazole antifungal agents
CA2731941C (en) 2008-08-12 2016-09-27 Merck Sharp & Dohme Corp. Derivatives of enfumafungin as inhibitors of(1,3)-beta.-d-glucan synthase
WO2016118396A1 (en) 2015-01-19 2016-07-28 Scynexis, Inc. Novel salts and polymorphs of scy-078

Also Published As

Publication number Publication date
PL3247711T3 (pl) 2022-06-27
ES2913111T3 (es) 2022-05-31
US10370406B2 (en) 2019-08-06
EP3247711B1 (en) 2022-03-09
PT3247711T (pt) 2022-05-16
LT3247711T (lt) 2022-05-25
WO2016118396A1 (en) 2016-07-28
EP3247711A1 (en) 2017-11-29
US20190359648A1 (en) 2019-11-28
HK1247196A1 (zh) 2018-09-21
EA036874B1 (ru) 2020-12-30
SI3247711T1 (sl) 2022-07-29
US20210395296A1 (en) 2021-12-23
US10927142B2 (en) 2021-02-23
US10174074B2 (en) 2019-01-08
EP4039684A1 (en) 2022-08-10
HRP20220544T1 (hr) 2022-08-05
US20160207956A1 (en) 2016-07-21
US20190153024A1 (en) 2019-05-23
RS63234B1 (sr) 2022-06-30
HUE058721T2 (hu) 2022-09-28
EA201791645A1 (ru) 2018-01-31

Similar Documents

Publication Publication Date Title
DK3371171T3 (da) Inhibitorer af RET
DK3368069T3 (da) Anvendelse af myostatininhibitorer og kombinationsterapier
DK3259253T3 (da) Sulfonylureaer og relaterede forbindelser og brug af samme
DK3102576T3 (da) Dihydropyrrolopyridininhibitorer af ror-gamma
DK3377059T3 (da) Hæmmere af cxcr2
DK3851537T3 (da) Behandling af hyperbilirubinæmi
DK3137169T3 (da) Hæmmere af lysin-specifik demethylase-1
DK3262046T3 (da) Salte af pi3k-inhibitor og fremgangsmåder til fremstilling deraf
DK3423451T3 (da) Inhibitorer af wdr5-protein-proteinbinding
DK3185868T3 (da) Hidtil ukendte ULK1-inhibitorer og fremgangsmåder til anvendelse af samme
DK3160956T3 (da) Inhibitorer af lysin-specifik demethylase-1
DK3442972T3 (da) Bromdomænehæmmere
DK3164380T3 (da) Hæmmere af lysinspecifik demethylase-1
DK3288553T3 (da) Kombinationer af cannabinoider og n-acylethanolaminer
DK3215493T3 (da) Syntese af copanlisib og dihydrochloridsalt deraf
DK3457851T3 (da) Derivater af sobetirom
DK3331879T3 (da) Benzazolforbindelser og fremgangsmåder til fremstilling og anvendelse af forbindelserne
DK3365323T3 (da) Salte af tetracycliner
DK3307267T3 (da) Behandling af multipel sklerose
DK3429998T3 (da) Fremgangsmåde til fremstilling af quinolin-2-yl-phenylaminderivater og disses salte
DK3506904T3 (da) Behandling af demens
DK3242947T3 (da) Genterapi og elektroporese til behandling af maligniteter
DK3390422T3 (da) Krystalformer af lnt
DK3368044T3 (da) Behandling af hepatisk steatose-relateret oligo-ovulation
DK3233105T3 (da) Hidtil ukendt kombination og anvendelse